Literature DB >> 33732566

Pituitary Apoplexy Attributed to COVID-19 Infection in the Absence of an Underlying Macroadenoma or Other Identifiable Cause.

Stephen J Bordes1, Simone Phang-Lyn2, Edinson Najera3, Hamid Borghei-Razavi4, Badih Adada3.   

Abstract

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is responsible for an array of extrapulmonary manifestations, including direct and indirect neurological complications. Currently, all published cases noting pituitary apoplexy in patients with COVID-19 have discovered underlying pituitary macroadenomas. Herein, we describe the first documented case, to our knowledge, of pituitary apoplexy attributed solely to COVID-19 in the absence of other identifiable causes. While much remains to be discovered and understood regarding COVID-19, we discuss the potential pathophysiology of COVID-19-associated pituitary apoplexy and raise awareness of this clinical complication.
Copyright © 2021, Bordes et al.

Entities:  

Keywords:  covid-19; neurosurgery; pituitary apoplexy; sars-cov-2

Year:  2021        PMID: 33732566      PMCID: PMC7956048          DOI: 10.7759/cureus.13315

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

Review 1.  Coronavirus Disease 2019 (COVID-19) From the Point of View of Neurologists: Observation of Neurological Findings and Symptoms During the Combat Against a Pandemic.

Authors:  Ayşe Nur Özdağ Acarli; Bedia Samanci; Esme Ekizoğlu; Arman Çakar; Nermin Görkem Şirin; Tuncay Gündüz; Yeşim Parman; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2020-05-01       Impact factor: 1.339

Review 2.  Pituitary apoplexy: pathophysiology, diagnosis and management.

Authors:  Andrea Glezer; Marcello D Bronstein
Journal:  Arch Endocrinol Metab       Date:  2015-06       Impact factor: 2.309

3.  Pituitary macroadenoma apoplexy in a severe acute respiratory syndrome-coronavirus-2-positive testing: Causal or casual?

Authors:  Saúl Solorio-Pineda; César Adán Almendárez-Sánchez; Abrahan Alfonso Tafur-Grandett; Gabriel Arturo Ramos-Martínez; Raúl Huato-Reyes; Milton Inocencio Ruiz-Flores; Antonio Sosa-Najera
Journal:  Surg Neurol Int       Date:  2020-09-25

4.  Pregnancy and pituitary disorders.

Authors:  Z Karaca; F Tanriverdi; K Unluhizarci; F Kelestimur
Journal:  Eur J Endocrinol       Date:  2009-11-24       Impact factor: 6.664

Review 5.  Pituitary Apoplexy.

Authors:  Claire Briet; Sylvie Salenave; Jean-François Bonneville; Edward R Laws; Philippe Chanson
Journal:  Endocr Rev       Date:  2015-09-28       Impact factor: 19.871

6.  Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children.

Authors:  Omar Abdel-Mannan; Michael Eyre; Ulrike Löbel; Alasdair Bamford; Christin Eltze; Biju Hameed; Cheryl Hemingway; Yael Hacohen
Journal:  JAMA Neurol       Date:  2020-11-01       Impact factor: 29.907

7.  A Rare Case of SARS-CoV-2 Infection Associated With Pituitary Apoplexy Without Comorbidities.

Authors:  Ritwik Ghosh; Dipayan Roy; Devlina Roy; Arpan Mandal; Aloke Dutta; Dinabandhu Naga; Julián Benito-León
Journal:  J Endocr Soc       Date:  2021-01-02

8.  Neuropathological Features of Covid-19.

Authors:  Isaac H Solomon; Erica Normandin; Shamik Bhattacharyya; Shibani S Mukerji; Kiana Keller; Ahya S Ali; Gordon Adams; Jason L Hornick; Robert F Padera; Pardis Sabeti
Journal:  N Engl J Med       Date:  2020-06-12       Impact factor: 91.245

9.  Pituitary apoplexy associated with acute COVID-19 infection and pregnancy.

Authors:  Julie L Chan; Kimberly D Gregory; Sarah S Smithson; Mariam Naqvi; Adam N Mamelak
Journal:  Pituitary       Date:  2020-09-11       Impact factor: 4.107

Review 10.  Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review.

Authors:  Evan C Chen; Rebecca L Zon; Elisabeth M Battinelli; Jean M Connors
Journal:  Oncologist       Date:  2020-08-31       Impact factor: 5.837

View more
  6 in total

Review 1.  Case Report: Hypothalamic Amenorrhea Following COVID-19 Infection and Review of Literatures.

Authors:  Paolo Facondo; Virginia Maltese; Andrea Delbarba; Ilenia Pirola; Mario Rotondi; Alberto Ferlin; Carlo Cappelli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

2.  Optic neuritis concomitant with pituitary macroadenoma in a patient with active COVID-19 infection: A case report.

Authors:  Mohammed Maan Al-Salihi; Md Moshiur Rahman; Maryam Sabah Al-Jebur; Sabrina Rahman; Ivan David Lozada-Martinez; Raphia Rahman; Luis Rafael Moscote-Salazar
Journal:  Int J Surg Open       Date:  2021-08-25

Review 3.  COVID-19 and the pituitary.

Authors:  Stefano Frara; Agnese Allora; Laura Castellino; Luigi di Filippo; Paola Loli; Andrea Giustina
Journal:  Pituitary       Date:  2021-05-03       Impact factor: 3.599

Review 4.  COVID-19 and hypopituitarism.

Authors:  Stefano Frara; Paola Loli; Agnese Allora; Chiara Santini; Luigi di Filippo; Pietro Mortini; Maria Fleseriu; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2021-08-13       Impact factor: 9.306

5.  Impact of COVID-19 on the Endocrine System: A Mini-review.

Authors:  Sophie A Clarke; Ali Abbara; Waljit S Dhillo
Journal:  Endocrinology       Date:  2022-01-01       Impact factor: 4.736

Review 6.  Coronavirus Disease 2019 and Pituitary Apoplexy: A Single-Center Case Series and Review of the Literature.

Authors:  Rafael Martinez-Perez; Michael W Kortz; Benjamin W Carroll; Daniel Duran; James S Neill; Gustavo D Luzardo; Marcus A Zachariah
Journal:  World Neurosurg       Date:  2021-06-12       Impact factor: 2.104

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.